CN Healthy Food Tech Group Corp. (UCFI) stock analysis
Close on Nov 11, 2026Market cap $287.82MP/E 35.8Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Weak7 of 30 checks passed
CN Healthy Food Tech passes 7 of the 30 checks behind our score; 18 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 2/6
- Past performance
- 2/6
- Financial health
- 3/6
- Dividend
- 0/6
What stands out
Interest well covered
Operating income covers interest expense 40.4 times.
Low bankruptcy risk
The Altman Z-score is 17.77; above 3 is the safe zone and below 1.8 the distress zone.
Growing faster than the industry
Revenue grew 33.9% over the last twelve months; the Food and Kindred Products median is 1.4%.
Gross margin improving
Gross margin was 72.6% over the last twelve months, against 63.2% a year earlier.
What to watch
Margin of safety under 20%
The price is 63.0% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $5.51 is above our fair value estimate of $3.38.
P/E above the industry
CN Healthy Food Tech's P/E of 35.8 is above the Food and Kindred Products median of 21.0.
P/B above the industry
CN Healthy Food Tech's price-to-book of 12.33 is above the Food and Kindred Products median of 1.73.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E above the industry
CN Healthy Food Tech's P/E of 35.8 is above the Food and Kindred Products median of 21.0.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/B above the industry
CN Healthy Food Tech's price-to-book of 12.33 is above the Food and Kindred Products median of 1.73.
Trading above fair value
The share price of $5.51 is above our fair value estimate of $3.38.
Margin of safety under 20%
The price is 63.0% above fair value, so there is no margin of safety.
Growth2/6
Revenue growth over 3 years
Needs three years of positive revenue.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing faster than the industry
Revenue grew 33.9% over the last twelve months; the Food and Kindred Products median is 1.4%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin improving
Gross margin was 72.6% over the last twelve months, against 63.2% a year earlier.
Past performance2/6
Return on equity
Needs positive equity and five years of results.
Return on invested capital
Needs operating income and invested capital.
Return on equity above the industry
CN Healthy Food Tech's return on equity of 39.2% is above the Food and Kindred Products median of -15.0%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin above the industry
CN Healthy Food Tech's net margin of 24.6% is above the Food and Kindred Products median of -4.1%.
Financial health3/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest well covered
Operating income covers interest expense 40.4 times.
Short-term assets cover short-term debts
Current assets are 2.35 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 17.77; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
CN Healthy Food Tech has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$3.38
The share price is 63% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 21.0× | – | 21.0× | $3.23 | 44% |
| EV/EBITDA | 13.5× | – | 13.5× | $3.79 | 39% |
| Earnings power | 7.4% cost of equity | – | – | $2.81 | 17% |
| Fair value | $3.38 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Food and Kindred Products median 21.0
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
High risk
- Average value traded per day
- $0
- Value traded per 1% price move
- –
Downside
Low risk
- Typical loss in a bad month
- 0.0%
- Volatility (annualized)
- 0%
- Sharpe ratio, 1 year
- –
- Beta to the S&P 500 (5Y)
- -0.20
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2021 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +144.6% | – | – | – | |
| Gross profit | +144.1% | – | – | – | |
| Operating income | +112.5% | – | – | – | |
| Net income | +110.5% | – | – | – | |
| EPS, diluted | +112.5% | – | – | – |
Returns and balance sheet
5 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2021 | FY2021 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | 54.8% | |
| Return on assets | – | – | 17.6% | |
| Current ratio | – | – | 1.50 | |
| Interest coverage | – | – | -168.1× | |
| Capex to revenue | – | – | 2.6% | |
| Diluted shares | – | – | 49M |
Cash use needs five years of cash flow figures
CN Healthy Food Tech does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 30.3% | 0.58× | 3.11× | 54.8% |
| FY2024 | 35.2% | 0.19× | 11.14× | 73.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$8.41M
- Cash generatingOperating cash flow above zero-$9.04M
- Return on assets improvedROA up on the prior year5.7% → 16.6%
- Earnings backed by cashOperating cash flow above net income-$9.04M vs $8.41M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose1.10 → 1.50
- No dilutionShare count did not rise48M → 49M
- Gross margin improvedGross margin up on the prior year66.48% → 66.34%
- More efficientAsset turnover rose0.16 → 0.55
See a number that looks wrong?